AbCellera Biologics Earning Date (ABCL)

USA |NASDAQ |USD

ABCL Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 10, 2022 Jun 2022 $0.08 - $-0.01
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 10, 2022 Jun 2022 $84.85M - $27.64M

Abcellera Biologics's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.

ABCL Earnings Date & History Chart

ABCL Earnings & Revenue Forecast

ABCL Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 7 $0.08 $-0.11 $0.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $0.25 $-0.03 $0.74
Dec 2023 7 $-0.34 $-0.57 $-0.14

ABCL Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 1 $0.09 $0.08 $-0.04
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $0.23 $0.25 $-0.08
Dec 2023 0 / 0 $-0.34 $-0.34 $-0.35

ABCL Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 7 $84.85M $9.53M $154.11M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 8 $299.41M $150.00M $522.75M
Dec 2023 7 $84.80M $49.48M $131.65M

ABCL Earnings Date & Revenue History

ABCL Earnings History

|
Show More
Show More

ABCL Revenue History

|
Show More
Show More

Abcellera Biologics Next Earnings Date & Report

ABCL Next Earnings Date & Report Preview: Jun 2022 (FQ)

ABCL's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Abcellera Biologics's next quarterly earnings is $0.08, with a low EPS estimation of $-0.11, and a high estimation of $0.24.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $0.09, the last 2 month trend is $0.08, and the 3 month trend is $-0.04.

Based on analysts, the average revenue estimation is $84.85M, with a low revenue estimation of $9.53M, and a high estimation of $154.11M.

Abcellera Biologics Previous Earnings Dates & Reports

ABCL Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Abcellera Biologics's previous earnings date was May 10, 2022 for its fiscal quarter ended Mar 31, 2022.

ABCL Previous Earnings Date & Report Recap: Dec 2021 (FY)

Abcellera Biologics's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.

ABCL's earnings per share (EPS) was $0.47, missing the consensus analysts forecast of $0.50 by -6.00% , and higher than the previous year's EPS (Dec 2020) by 34.55%.

Revenues were $11.61M, worse than the forecast of $375.20M by -96.91%, and down by -95.02% from previous year's revenue.

The company reported a net income of $-2.21M.

Abcellera Biologics reported a free cash flow of $-1.30M for its fiscal year, compared to $8.02M a year ago.

The company ended the fiscal year with $4.25M in total debt, an increase of 38.73% compared to the previous year.